$8.86
1.96%
Nasdaq, Aug 29, 10:01 pm CET

CryoPort Stock price

$8.86
+1.30 17.20% 1M
+3.29 59.07% 6M
+1.08 13.88% YTD
-0.14 1.56% 1Y
-27.16 75.40% 3Y
-46.62 84.03% 5Y
+6.05 215.30% 10Y
-711.14 98.77% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
+0.17 1.96%

Key metrics

Basic
Market capitalization
$443.6m
Enterprise Value
$204.8m
Net debt
positive
Cash
$426.0m
Shares outstanding
50.3m
Valuation (TTM | estimate)
P/E
6.7 | negative
P/S
2.2 | 2.6
EV/Sales
1.0 | 1.2
EV/FCF
negative
P/B
0.9
Financial Health
Equity Ratio
57.1%
Return on Equity
-30.5%
ROCE
-4.3%
ROIC
-10.0%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$202.7m | $173.9m
EBITDA
$-1.5m | $-2.2m
EBIT
$-32.2m | $-40.7m
Net Income
$67.3m | $-17.7m
Free Cash Flow
$-37.7m
Growth (TTM | estimate)
Revenue
-10.2% | -23.9%
EBITDA
96.7% | 94.0%
EBIT
56.5% | 39.3%
Net Income
137.3% | 85.6%
Free Cash Flow
16.2%
Margin (TTM | estimate)
Gross
45.7%
EBITDA
-0.7% | -1.3%
EBIT
-15.9%
Net
33.2% | -10.2%
Free Cash Flow
-18.6%
More
EPS
$1.3
FCF per Share
$-0.8
Short interest
6.5%
Employees
1k
Rev per Employee
$210.0k
Show more

Is CryoPort a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

CryoPort Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a CryoPort forecast:

11x Buy
73%
4x Hold
27%

Analyst Opinions

15 Analysts have issued a CryoPort forecast:

Buy
73%
Hold
27%

Financial data from CryoPort

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
203 203
10% 10%
100%
- Direct Costs 110 110
16% 16%
54%
93 93
2% 2%
46%
- Selling and Administrative Expenses 126 126
16% 16%
62%
- Research and Development Expense 16 16
15% 15%
8%
-1.49 -1.49
97% 97%
-1%
- Depreciation and Amortization 31 31
4% 4%
15%
EBIT (Operating Income) EBIT -32 -32
56% 56%
-16%
Net Profit 67 67
137% 137%
33%

In millions USD.

Don't miss a Thing! We will send you all news about CryoPort directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoPort Stock News

Positive
The Motley Fool
26 days ago
Cryoport (CYRX) Q2 Revenue Jumps 14%
Neutral
Seeking Alpha
26 days ago
Cryoport, Inc. (NASDAQ:CYRX ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Jerrell W. Shelton - Chairman, President & CEO Mark W.
Neutral
PRNewsWire
27 days ago
Second quarter revenue increased 14% year-over-year to $45.5 million Commercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 million Life Sciences Services revenue rose 21% year-over-year, including a 28% increase in BioStorage/BioServices revenue Launched strategic partnership agreement with the DHL Group; closed CRYOPDP divestiture Company reaffirms full year 2025 revenue ...
More CryoPort News

Company Profile

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Head office United States
CEO Jerrell Shelton
Employees 1,098
Founded 1990
Website www.cryoport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today